These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 23064420

  • 1. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
    He L, Yang X, Cao X, Liu F, Quan M, Cao J.
    Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
    [Abstract] [Full Text] [Related]

  • 2. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
    Wang J, Zheng X, Zeng G, Zhou Y, Yuan H.
    Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A, Wang J, Wu M, Zhang X, Zhang H.
    Eur J Pharmacol; 2015 Jan 15; 747():71-87. PubMed ID: 25498792
    [Abstract] [Full Text] [Related]

  • 4. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
    Wang JG, Zheng XX, Zeng GY, Zhou YJ, Yuan H.
    Oncol Rep; 2014 Jan 15; 31(1):488-96. PubMed ID: 24247909
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, Ke Q, Liu Y, Li P, Cui X, Shen A, Cheng C.
    Med Oncol; 2009 Jan 15; 26(2):178-85. PubMed ID: 18937079
    [Abstract] [Full Text] [Related]

  • 6. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F, Dong X, Lin P, Jiang J.
    Int J Mol Sci; 2018 Jan 23; 19(2):. PubMed ID: 29360760
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
    Qu K, Xu X, Liu C, Wu Q, Wei J, Meng F, Zhou L, Wang Z, Lei L, Liu P.
    Cancer Lett; 2013 Apr 30; 331(1):105-14. PubMed ID: 23262037
    [Abstract] [Full Text] [Related]

  • 9. [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].
    Gong XD, Yuan HH, Wang JY, Guo YH, Shi J, Jiang B.
    Zhonghua Zhong Liu Za Zhi; 2013 Aug 30; 35(8):572-8. PubMed ID: 24314213
    [Abstract] [Full Text] [Related]

  • 10. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells.
    Yang J, Yang Y, Tian L, Sheng XF, Liu F, Cao JG.
    World J Gastroenterol; 2011 Oct 14; 17(38):4298-307. PubMed ID: 22090786
    [Abstract] [Full Text] [Related]

  • 11. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
    Wu QF, Liu C, Tai MH, Liu D, Lei L, Wang RT, Tian M, Lü Y.
    Acta Pharmacol Sin; 2010 Mar 14; 31(3):361-6. PubMed ID: 20154714
    [Abstract] [Full Text] [Related]

  • 12. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ, Tang Q, Wu J, Chen Y, Zheng F, Dai Z, Hann SS.
    J Exp Clin Cancer Res; 2016 Mar 31; 35():59. PubMed ID: 27036874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.
    Xiang HL, Liu F, Quan MF, Cao JG, Lv Y.
    World J Gastroenterol; 2012 Sep 07; 18(33):4618-26. PubMed ID: 22969238
    [Abstract] [Full Text] [Related]

  • 15. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS, Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, Lu ZB, Yang HY, Yu LZ, Mo ZX, Yu ZL.
    Phytomedicine; 2019 Aug 07; 61():152843. PubMed ID: 31039533
    [Abstract] [Full Text] [Related]

  • 16. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST, Ho HJ, Lin JT, Shieh JJ, Wu CY.
    Cell Death Dis; 2017 Feb 23; 8(2):e2626. PubMed ID: 28230855
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC, Meng FD, Qu K, Wang ZX, Wu QF, Zhang LQ, Pang Q, Liu C.
    Acta Pharmacol Sin; 2015 Feb 23; 36(2):241-51. PubMed ID: 25557114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.